🔗 Share this article

The top legal official in Texas Paxton is taking legal action against the producers of Tylenol, asserting the corporations hid alleged dangers that the drug created to pediatric brain development.

The lawsuit follows four weeks after President Donald Trump promoted an unverified association between consuming acetaminophen - also known as paracetamol - throughout gestation and autism in offspring.

Paxton is suing Johnson & Johnson, which previously sold the drug, the only pain reliever recommended for pregnant women, and Kenvue, which now manufacturers it.

In a official comment, he said they "deceived the public by making money from suffering and promoting medication ignoring the potential hazards."

The company states there is lacking scientific proof tying Tylenol to autism spectrum disorder.

"These companies deceived for years, deliberately risking millions to increase profits," the attorney general, from the Republican party, stated.

The manufacturer said in a statement that it was "very worried by the spread of false claims on the safety of paracetamol and the likely effects that could have on the well-being of women and children in America."

On its online platform, the company also said it had "consistently assessed the relevant science and there is no credible data that shows a proven link between taking acetaminophen and autism spectrum disorder."

Groups acting on behalf of doctors and medical practitioners concur.

The American College of Obstetricians and Gynecologists has said acetaminophen - the key substance in acetaminophen - is a restricted selection for women during pregnancy to treat discomfort and elevated temperature, which can present major wellness concerns if ignored.

"In more than two decades of research on the use of paracetamol in gestation, no reliable research has conclusively proven that the use of acetaminophen in any stage of pregnancy leads to neurodevelopmental disorders in offspring," the organization said.

The court filing references latest statements from the previous government in asserting the medication is potentially dangerous.

In recent weeks, the former president generated worry from medical authorities when he advised women during pregnancy to "struggle intensely" not to use acetaminophen when sick.

The FDA then released a statement that physicians should consider limiting the consumption of acetaminophen, while also mentioning that "a proven link" between the drug and autism spectrum disorder in young ones has remains unverified.

Health Secretary Robert F Kennedy Jr, who manages the FDA, had promised in spring to initiate "extensive scientific investigation" that would determine the cause of autism in a limited time.

But authorities warned that finding a unique factor of autism - considered by experts to be the consequence of a complicated interplay of inherited and surrounding conditions - would prove challenging.

Autism spectrum disorder is a form of lifelong neurodivergence and impairment that influences how persons encounter and engage with the world, and is identified using medical professional evaluations.

In his lawsuit, the attorney general - a Trump ally who is seeking US Senate - alleges Kenvue and Johnson & Johnson "intentionally overlooked and sought to suppress the research" around acetaminophen and autism spectrum disorder.

This legal action aims to force the firms "destroy any promotional materials" that claims acetaminophen is reliable for expectant mothers.

The court case mirrors the complaints of a assembly of guardians of minors with autism spectrum disorder and attention deficit hyperactivity disorder who filed suit against the producers of Tylenol in recently.

The court rejected the legal action, stating investigations from the family's specialists was lacking definitive proof.